[Criteria of permissible risk in cytostatic therapy of acute leukemias].
D000293:Adolescent; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000517:prevention & control / Q000556:secondary*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D012306:Risk
D000964:Antimetabolites, Antineoplastic
O kriteriiakh dopustimogo riska tsitostaticheskoĭ terapii ostrykh leĭkozov.